Kopp Funds’s Regeneron Pharmaceuticals REGN Stock Holding History

Kopp Funds’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	$1.26M	Buy	+4,597	New	+$1.32M	0.57%	32

Other funds holding REGN

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Kopp Funds's REGN Position: Q4 2013 in Review

Kopp Funds opened a new position in Regeneron Pharmaceuticals (REGN) in Q4 2013: 4,597 shares worth $1.26M. The stake represents 0.57% of the portfolio and ranks #32 among its holdings.

437 funds tracked by Wall St. Rank hold REGN as of Q4 2013.

Kopp Funds held 4,597 shares of Regeneron Pharmaceuticals worth $1.26M as of Q4 2013.
Regeneron Pharmaceuticals was a new Kopp Funds position in Q4 2013.
Regeneron Pharmaceuticals made up 0.57% of Kopp Funds's portfolio in Q4 2013, its #32 holding.
437 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2013.

Based on Kopp Funds's 13F filing for Q4 2013, filed 21 Jan 2014.